Susceptibilities of Candida spp. to antifungal agents visualized by two-dimensional scatterplots of relative growth

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 3, 1996, Pages 588-594

  Odds, F C ^a   Dams, G ^a   Just, G ^b   Lewi, P ^a  

^a JANSSEN RESEARCH FOUNDATION   (Belgium)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; KETOCONAZOLE; PYRROLE DERIVATIVE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CONTROLLED STUDY; DRUG SENSITIVITY; FUNGUS GROWTH; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; HUMANS; MICROBIAL SENSITIVITY TESTS; PHENOTYPE; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME;

EID: 0030051151     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.3.588     Document Type: Article

References (33)

1. Anaissie, E. 1992. Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review. Clin. Infect. Dis 14:S43-S53
2. Barchiesi, F., A. L. Colombo, D. A. McGough, A. W. Fothergill, and M. G. Rinaldi. 1994. In vitro activity of itraconazole against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus. Antimicrob, Agents Chemother. 38: 1530-1533
3. Cameron, M. L., W. A. Schell, S. Bruch, J. A. Bartlett, H. A. Waskin, and J. R. Perfect. 1993. Correlation of in vitro fluconazole resistance of Candida isolates in relation to therapy and symptoms of individuals seropositive for human immunodeficiency virus type 1. Antimicrob Agents Chemother. 37: 2449-2453.
4. Chavanet, P., J. Lopez, M. Grappin, A. Bonnin, M. Duong, A. Waldner, M. Buisson, P. Camerlynck, and H. Portier. 1994. Cross-sectional study of the susceptibility of Candida isolates, to antifungat drugs and in vitro-in vivo correlation in HIV-infected patients. AIDS 8:945-950.
5. Coste, T., T. Barale, G. Reboux, D. Talon, and J. Y. Cahn. 1990. Prophylaxie antifongique par fluconazole: son influence sur l'augmentation de la frequence d'isolement de Candida glubrata Bull. Soc. Fr. Mycol. Med. 19:151-154.
6. Dellion, S., L. Improvisi, B. Dupont, and F. Dromer. 1995. Diversity among yeast isolated from patients with AIDS and oral candidosis: focus on fluconazole susceptibility testing results. J. Mycol. Med. 5:98-101.
7. Demontelos, M., H. Demontclos, and J. P. Flandrois. 1992. A 4-agent comparative study of 2 kits for determining the susceptibility of yeasts to antifungal agents. Pathol. Biol. 40:495-499
8. Espinel-Ingroff, A. 1994. E test for antifungal susceptibility testing of yeasts. Diagn Microbiol Infect. Dis. 19:217-220.
9. Galgiani, J. N., M. S. Bartlett, A. Espinel-Ingroff, R. A. Fromtling, M. A. Pfaller, and M. G. Rinaldi. 1992. Reference method for broth dilution antifungal susceptibility testing of yeasts, proposed standard. NCCLS publication M27-P. National Committee for Clinical Laboratory Standards, Villanova, Pa.
10. Hald, A. 1952. Statistical theory with engineering applications. John Wiley & Sons, New York.
11. Johnson, E. M., M. D. Richardson, and D. W. Warnock. 1984. In-vitro resistance to imidazole antifungals in Candida albicans. J. Antimicrob. Chemother. 13:547-558.
12. Odds, F. C. 1985. Laboratory tests for the activity of imidazole and triazole antifungal agents in vitro. Semin. Dermatol. 4:260-270.
13. Odds, F. C. 1992. Relative growth of Candida species at single antifungal concentrations: a new approach to antifungal susceptibility testing. Antimicrob. Agents Chemother. 36:1727-1737.
14. Odds, F. C. 1993. Effects of temperature on anti-Candida activities of antifungal antibiotics Antimicrob. Agents Chemother. 37:685-691.
15. Odds, F. C. 1993. Resistance of yeasts to azole-derivative antifungals. J. Antimicrob. Chemother. 31:463-471.
16. Odds, F. C., L. Vranekx, and F. Woestenborghs. 1995. Antifungal susceptibility testing of yeasts: evaluation of technical variables for test automation. Antimicrob. Agents Chemother. 39:2051-2060.
17. Pfaller, M. A., and A. L. Barry. 1994. Evaluation of a novel colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates. J. Clin. Microbiol. 32:1992-1996.
18. Philpot, C. M., and D. Charles. 1993 Determination of sensitivity to antifungal drugs - evaluation of an API kit Br J. Biomed. Sci. 50:27-30.
19. Philpott-Howard, J. N., J. J. Wade, G. J. Mufti, K. W. Brammer, and G. Ehninger. 1993. Randomized comparison of oral fluconazole versus oral polyenes for the prevention of fungal infection in patients at risk of neutropenia. J. Antimicrob Chemother. 31:973-984.
20. Price, M. F., M. T. LaRocco, and L. O. Gentry. 1994. Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period. Antimicrob. Agents Chemother. 38:1422-1424.
21. Quindós, G., R. Salesa, A. J. Carrillo-Muñoz, V. Lipperheide, L. Jáudenes, R. San Millán, J. Torres-Rodríguez, and J. Pontón. 1994. Multicenter evaluation of ATB fungus: a standardized micromethod for yeast susceptibility testing. Chemotherapy 40:245-251.
22. Rex, J. H., M. A. Pfaller, M. G. Rinaldi, A. Polak, and J. N. Galgiani. 1993. Antifungal susceptibility testing. Clin Microbiol. Rev. 6:367-381.
23. Rex, J. H., M. G. Rinaldi, and M. A. Pfaller. 1995. Resistance of Candida species to fluconazole. Antimicrob. Agents Chemother. 39:1-8.
24. Ruhnke, M., A. Eigler, I. Tonnagen, B. Geiseler, E. Engelmann, and M. Trautmann. 1994. Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection. J. Clin. Microbiol. 32:2092-2098.
25. Ryley, J. F., R. G. Wilson, and K. J. Barrett-Bee. 1984. Azole resistance in Candida albicans. Sabouraudia 22:53-63.
26. Sandven, P., A. Bjørneklett, A. Maeland, and the Norwegian Yeast Study Group. 1993. Susceptibilities of Norwegian Candida albicans strains to flucunazole. emergence of resistance Antimicrob. Agents Chemother. 37:2443-2448.
27. Snyder, W. V. 1978. Contour plotting. ACM Trans. Math. Software 4:290-294.
28. Soll, D. R. 1992. High-frequency switching in Candida albicans. Clin. Microbiol. Rev. 5:183-203.
29. Troillet, N., C. Durussel, J. Bille, M. P. Glauser, and J. P. Chave. 1993. Correlation between in vitro susceptibility of Candida albicans and fluconazole-resistant oropharyngeal candidiasis in HIV-infected patients. Eur. J. Clin. Microbiol. Infect. Dis. 12:911-915.
30. Troke, P. F. 1993 In vitro and experimental in vivo activities of fluconazole against some fungi causing cutaneous mycoses, p. 199-214. In J. W. Rippon and R. A Fromtling (ed.), Cutaneous antifungal agents. Marcel Dekker, Inc, New York.
31. Vanden Boscche, H., P. Marichal, and F. C. Odds. 1994. Molecular mechanisms of drug resistance in fungi Trends Microbiol. 2:393-400.
32. Warnock, D. W. 1992. Azole drug resistance in Candida species. J. Med Microbiol. 37:225-226.
33. Weber, D. J., W. A. Rutala, G. P. Samsa, M. B. Wilson, and K. K. Hoffmann. 1992 Relative frequency of nosocomial pathogens at a university hospital during the decade 1980 to 1989. Am. J. Infect. Control 20:192-197